Theranos trial
https://www.newyorker.com/news/q-and-a/what-john-carreyrou-expects-at-the-trial-of-elizabeth-holmes
In Conversation
David Petraeus on Errors in Afghanistan
Billie Jean King Says to Follow the Money
Michael Stipe Wants to Make Mistakes
Aly Raisman on Reckonings in Gymnastics
Q. & A.
What John Carreyrou Expects at the Trial of Elizabeth Holmes
The author of “Bad Blood†discusses the Theranos founder’s defense strategies and the likelihood that he himself will be called as a witness.
By Helen Rosner
September 21, 2021
Elizabeth Holmes wearing a mask arrives at a courthouse in California.
“There’s an entitlement to Elizabeth Holmes and her clan that you can’t underestimate,†the journalist John Carreyrou says.Source photograph by David Paul Morris / Bloomberg / Getty
The federal trial of Elizabeth Holmes, the founder and former C.E.O. of the now defunct medical-testing tech startup Theranos, began on August 31st, three years after Holmes’s indictment on numerous counts of fraud and conspiracy to commit wire fraud. Theranos was once valued at more than nine billion dollars. It employed upward of seven hundred people and had a board of directors stacked with the likes of Henry Kissinger and James Mattis. Then, six years ago, the company collapsed like a soufflé, following a Wall Street Journal exposé by the reporter John Carreyrou, who wrote that the company’s supposedly revolutionary technology—a proprietary lab machine that could run hundreds of medical tests using mere drops of blood drawn from a finger prick—was not at all what Theranos claimed it to be.